JP7633156B2 - 方法及び組成物 - Google Patents

方法及び組成物 Download PDF

Info

Publication number
JP7633156B2
JP7633156B2 JP2021521504A JP2021521504A JP7633156B2 JP 7633156 B2 JP7633156 B2 JP 7633156B2 JP 2021521504 A JP2021521504 A JP 2021521504A JP 2021521504 A JP2021521504 A JP 2021521504A JP 7633156 B2 JP7633156 B2 JP 7633156B2
Authority
JP
Japan
Prior art keywords
dap
acid
amino acid
mmol
trna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021521504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022505464A (ja
Inventor
ジェイソン チン
デゾ ニコラス ユーグニン
モハン マヘシュ
シャン タン
ドゥイ ピー グエン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Kingdom Research and Innovation
Original Assignee
United Kingdom Research and Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Kingdom Research and Innovation filed Critical United Kingdom Research and Innovation
Publication of JP2022505464A publication Critical patent/JP2022505464A/ja
Priority to JP2024186312A priority Critical patent/JP2025023942A/ja
Application granted granted Critical
Publication of JP7633156B2 publication Critical patent/JP7633156B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22069—SARS coronavirus main proteinase (3.4.22.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01026—Pyrrolysine-tRNAPyl ligase (6.1.1.26)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2021521504A 2018-10-26 2019-10-24 方法及び組成物 Active JP7633156B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024186312A JP2025023942A (ja) 2018-10-26 2024-10-23 方法及び組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1817444.1 2018-10-26
GBGB1817444.1A GB201817444D0 (en) 2018-10-26 2018-10-26 Methods and compositions
PCT/GB2019/053023 WO2020084307A1 (en) 2018-10-26 2019-10-24 Methods and compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024186312A Division JP2025023942A (ja) 2018-10-26 2024-10-23 方法及び組成物

Publications (2)

Publication Number Publication Date
JP2022505464A JP2022505464A (ja) 2022-01-14
JP7633156B2 true JP7633156B2 (ja) 2025-02-19

Family

ID=64560429

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021521504A Active JP7633156B2 (ja) 2018-10-26 2019-10-24 方法及び組成物
JP2024186312A Pending JP2025023942A (ja) 2018-10-26 2024-10-23 方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024186312A Pending JP2025023942A (ja) 2018-10-26 2024-10-23 方法及び組成物

Country Status (9)

Country Link
US (2) US12286657B2 (cg-RX-API-DMAC7.html)
EP (1) EP3870224B1 (cg-RX-API-DMAC7.html)
JP (2) JP7633156B2 (cg-RX-API-DMAC7.html)
CN (2) CN120607506A (cg-RX-API-DMAC7.html)
AU (2) AU2019369192B2 (cg-RX-API-DMAC7.html)
CA (1) CA3116567A1 (cg-RX-API-DMAC7.html)
DK (1) DK3870224T3 (cg-RX-API-DMAC7.html)
GB (1) GB201817444D0 (cg-RX-API-DMAC7.html)
WO (1) WO2020084307A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2852664B1 (en) 2012-05-18 2017-09-06 Medical Research Council Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase.
GB201817444D0 (en) 2018-10-26 2018-12-12 Res & Innovation Uk Methods and compositions
GB201906775D0 (en) 2019-05-14 2019-06-26 Res & Innovation Uk Synthetic genome
EP4399283A2 (en) * 2021-09-06 2024-07-17 Veraxa Biotech GmbH Novel aminoacyl-trna synthetase variants for genetic code expansion in eukaryotes
CN114195665A (zh) * 2021-12-14 2022-03-18 武汉世吉药业有限公司 一种高纯度ncaa的中和酸化工艺及设备
EP4328308A1 (en) * 2022-08-22 2024-02-28 Technische Universität Berlin Modified trna-synthetase for the incorporation of non-canonical amino acids

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015529208A (ja) 2012-08-31 2015-10-05 ストロ バイオファーマ インコーポレーテッド アジド基を含む修飾アミノ酸

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5275566B2 (ja) 2003-06-18 2013-08-28 ザ スクリプス リサーチ インスティチュート 反応性非天然アミノ酸遺伝コード付加
WO2005019415A2 (en) 2003-07-07 2005-03-03 The Scripps Research Institute Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
CA2549830A1 (en) 2003-12-18 2006-01-05 The Scripps Research Institute Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells
MX2007003142A (es) 2004-09-21 2007-07-04 Scripps Research Inst Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias.
MX2007004892A (es) 2004-10-27 2007-08-16 Scripps Research Inst Componentes de traduccion ortogonales para la incorporacion in vivo de aminoacidos no naturales.
US8431558B2 (en) 2004-11-01 2013-04-30 The Regents Of The University Of California Compositions and methods for modification of biomolecules
JP2007037445A (ja) 2005-08-02 2007-02-15 Institute Of Physical & Chemical Research tRNA合成方法、核酸、アミノアシルtRNA合成方法及び非天然型アミノ酸組み込み蛋白質の製造方法
WO2007090198A2 (en) 2006-02-01 2007-08-09 Encode Bio, Inc. Fluorescent assays using orthogonal trna - aminoacyl synthetase pairs
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
US20090110662A1 (en) 2007-04-30 2009-04-30 Intezyne Technologies, Inc. Modification of biological targeting groups for the treatment of cancer
CN101952428B (zh) 2007-09-20 2013-10-23 独立行政法人理化学研究所 突变体吡咯赖氨酰-tRNA合成酶以及使用该酶的非天然氨基酸整合蛋白质的制造方法
GB0721291D0 (en) 2007-10-30 2007-12-12 Medical Res Council Methods and compositions
GB2470770A (en) 2009-06-04 2010-12-08 Medical Res Council Incorporation of unnatural amino acids having an orthogonal functional group into polypeptides using orthogonal tRNA/tRNA synthetase pairs
GB0917240D0 (en) 2009-10-01 2009-11-18 Medical Res Council Incorporation of methyl lysine into poiypeptide
GB0917242D0 (en) 2009-10-01 2009-11-18 Medical Res Council Acetyl lysine incorporation with tRNA synthetase
MX368648B (es) 2010-04-15 2019-10-09 Seattle Genetics Inc Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
US8859629B2 (en) 2010-04-27 2014-10-14 Synaffix B.V. Fused cyclooctyne compounds and their use in metal-free click reactions
US20120077186A1 (en) 2010-05-07 2012-03-29 Oregon Health & Science University Use of cysteine-derived suppressor trnas for non-native amino acid incorporation
WO2011156686A2 (en) 2010-06-11 2011-12-15 The Regents Of The University Of Colorado, A Body Corporate Method for synthesizing a cyclic multivalent peptide using a thiol-mediated reaction
ES2661095T3 (es) 2011-02-03 2018-03-27 European Molecular Biology Laboratory Aminoácidos no naturales que comprenden un grupo análogo de ciclooctinilo o trans-ciclooctenilo y usos de los mismos
GB201110815D0 (en) 2011-06-24 2011-08-10 Medical Res Council Incorporation of subtituted lysines into polypeptides
US20130066063A1 (en) 2011-09-09 2013-03-14 John Cooke Hodges Bicyclo[6.1.0]non-4-yne regents for chemical modification of oligonucleotides
GB201201100D0 (en) 2012-01-20 2012-03-07 Medical Res Council Polypeptides and methods
EP2852664B1 (en) 2012-05-18 2017-09-06 Medical Research Council Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase.
US9670521B2 (en) 2012-09-24 2017-06-06 Medimmune Limited Amino acid derivatives
WO2015100277A2 (en) * 2013-12-23 2015-07-02 University Of Rochester Methods and compositions for ribosomal synthesis of macrocyclic peptides
GB2528227A (en) 2014-03-14 2016-01-20 Medical Res Council Cyclopropene amino acids and methods
GB201419109D0 (en) 2014-10-27 2014-12-10 Medical Res Council Incorporation of unnatural amino acids into proteins
GB201613135D0 (en) 2016-07-29 2016-09-14 Medical Res Council Genome editing
IL321812A (en) * 2017-08-03 2025-08-01 Synthorx Inc Cytokine complexes for the treatment of autoimmune diseases
GB201817444D0 (en) 2018-10-26 2018-12-12 Res & Innovation Uk Methods and compositions
GB201906775D0 (en) 2019-05-14 2019-06-26 Res & Innovation Uk Synthetic genome
CN117881779A (zh) 2021-05-28 2024-04-12 英国研究与创新署 微生物及其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015529208A (ja) 2012-08-31 2015-10-05 ストロ バイオファーマ インコーポレーテッド アジド基を含む修飾アミノ酸

Also Published As

Publication number Publication date
EP3870224A1 (en) 2021-09-01
CN113226375A (zh) 2021-08-06
GB201817444D0 (en) 2018-12-12
JP2025023942A (ja) 2025-02-19
WO2020084307A1 (en) 2020-04-30
US20220010296A1 (en) 2022-01-13
DK3870224T3 (da) 2026-08-03
CN120607506A (zh) 2025-09-09
EP3870224B1 (en) 2026-07-08
US12286657B2 (en) 2025-04-29
JP2022505464A (ja) 2022-01-14
CN113226375B (zh) 2025-05-13
AU2019369192A1 (en) 2021-05-13
AU2025205622A1 (en) 2025-08-07
AU2019369192B2 (en) 2025-08-14
CA3116567A1 (en) 2020-04-30
US20250283066A1 (en) 2025-09-11

Similar Documents

Publication Publication Date Title
JP2025023942A (ja) 方法及び組成物
US20250340916A1 (en) Method for synthesizing peptides in cell-free translation system
CN110475785B (zh) 肽化合物及其制造方法、筛选用组合物以及肽化合物的选择方法
JP2023182649A (ja) コドン拡張のための変異tRNA
AU2018344883B2 (en) Cellular transport system for transferring a sulfonic acid construct carrying a cargo into the cytoplasm of a cell
US20240409524A1 (en) Compound having photocleavable moiety, conjugate, and screening method using same
JP2025512475A (ja) 二部分依存性チオエーテル導入ツールとしてのPapB
Schramma et al. Investigations into the Mechanism and Substrate Scope of AgaB and the Chemo-Enzymatic Total Synthesis of Streptide Natural Products
WO2026078118A1 (en) Compounds comprising non-canonical amino acids and uses thereof
Sangsuwan et al. Diethylphosphonate-containing aminoacyl-adenosine analog as inhibitor of bacterial tRNA-dependent transamidase
Kravetz SYNTHESIS OF NATURAL SUBSTRATE-MIMICKING COVALENT CROSSLINKERS TO INVESTIGATE NON-REDUCING ITERATIVE POLYKETIDE SYNTHASES
HK40104266A (en) Compound having photocleavable site, linker, and screening method using same
Nangreave Novel Strategies for Producing Proteins with Non-proteinogenic Amino Acids
Ahn Mechanistic studies of PLP-independent racemases
Huitt-Roehl Biosynthesis of fungal polyketide natural products: Structural and biochemical studies toward understanding programming and substrate specificity
Pham Novel inhibitors of the tRNA-dependent amidotransferase of" Helicobacter pylori": Peptides generated by phage display and dipeptide-like compounds
LT6159B (lt) Seleno baltymų (selprot) gavimas
Michaelides Towards the synthesis of diphthamide: the target of exotoxin a catalyzed ADP-ribosylation in eukaryotic elongation factor 2
Xie Adding unnatural amino acids to the genetic repertoire
Groff Photocontrol of biological activity
von Tesmar et al. Total biosynthesis of tomaymycin comprehensively monitored on the nonribosomal peptide megasynthetase
Liutkus Chlorinated amino acids in peptide production

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221017

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231023

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20231026

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240422

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241023

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20241112

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250114

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250206

R150 Certificate of patent or registration of utility model

Ref document number: 7633156

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150